Menu
Search
Home > Courses > New Insights in Hepatitis B and HIV Coinfection

New Insights in Hepatitis B and HIV Coinfection

New Insights in Hepatitis B and HIV Coinfection
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 9/13/2011
Review Date: 6/29/2012
Presenter
  • Marion Peters, MD
    ACTG Hepatitis Transformative Science Group
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Understand how to diagnose and treat HBV coinfection in HIV-positive patients.
  2. Know the causes of HBV reactivation in HIV coinfected patients.
  3. Monitor and manage end-stage liver disease in HBV- and HIV-infected patients.
Presenter Bio
Marion Peters, MD
Marion Peters, MD, is a hepatologist who is particularly interested in viral hepatitis. She has performed many studies of HBV infection, most recently the knowledge and screening among family members of Hepatitis B infected Asians in San Francisco. She leads the ACTG Hepatitis Transformative Science Group and the Women’s Interagency HIV study (WIHS) Hepatitis Working Group. She is studying new serum markers to evaluate liver fibrosis in WIHS. She is particularly interested in studying outcomes in Hepatitis B and new HCV drugs for patients with HCV, with and without HIV.
PRN Learning Modules